Corvus Pharmaceuticals CRVS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's net income?
- Corvus Pharmaceuticals (CRVS) reported net income of -$13.69M in Q1 2026.
- How has Corvus Pharmaceuticals's net income changed year-over-year?
- Corvus Pharmaceuticals's net income decreased by 190.1% year-over-year, from $15.19M to -$13.69M.
- What is the long-term trend for Corvus Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's net income has grown at a -22.9% compound annual growth rate (CAGR), from -$43.24M to -$15.28M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.